SB203580 promote EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway

Journal of Cellular Biochemistry

Volumn 83, Issue 4, 2001, Pages 585-596

  New, Liguo ^a   Li, Yingqiu ^a   Ge, Baoxue ^a   Zhong, Hongyin ^b   Mansbridge, Jonathan ^c   Liu, Kang ^c   Han, Jiahuai ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Advanced Tissue Sciences Liquidating Trust   (United States)

Author keywords

Differentiation; EGF; MAP kinase; NGF; SB203580

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN KINASE; SYNAPTOPHYSIN; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE P38; PEPTIDE FRAGMENT; PROTEIN C JUN; PROTO ONCOGENE PROTEINS C JUN; PYRIDINE DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; IMMUNOBLOTTING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; DNA VECTOR; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMAL; CELL DIFFERENTIATION; DRUG COMBINATIONS; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GENETIC VECTORS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; PYRIDINES; RATS; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034746841     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1253     Document Type: Article

References (35)

1. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: Differences between v-and c-Jun
2. Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells
3. Characterization of ERK1 activation site mutants and the effect onX recognition by MEK1 and MEK2.X
4. Tumor promoter modulation of epidermal growth factor- and nerve growth factor-induced adhesion and growth factor binding of PC12 pheochromocytoma cells
5. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
6. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
7. Independent human MAP-kinase signal transduction pathways defined byX MEK and MKK isoforms
8. A synthetic inhibitor of the mitogen-activated protein kinase cascade
9. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
10. Differentiation of PC12 cells with nerve growth factor is associated with induction of transin synthesis and release
11. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells
12. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo
13. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
14. Transcriptional regulation by extracellular signals: Mechanisms and specificity
15. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b
16. Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor
17. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2
18. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580
19. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
20. Rapid insulin-stimulated accumulation of an mRNA encoding a Proline-rich protein
21. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
22. NGF-induction of the metalloproteinase-transin/stromelysin in PC12 cells: Involvement of multiple protein kinases
23. Nerve growth factor induces protein-tyrosine phosphorylation
24. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation
25. Neuronal activity-dependent cell survival mediated by transcription factor MEF2
26. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases
27. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells
28. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
29. PRAK, a novel protein kinase regulated by the p38 MAP kinase
30. Intramolecular signal transduction in c-Jun
31. Phosphorylation of c-jun mediated by MAP kinases
32. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor
33. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor
34. Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells
35. Nerve growth factor induces the proto-oncogene c-jun in PC12 cells